Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Primo Brands Corp (Class A) | Tony W. Lee | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 64,512,579 | 218,618,368 | - | - | Class A Common Stock | |
| Primo Brands Corp (Class A) | Tony W. Lee | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 64,512,579 | 0 | - | - | Class B Common Stock | |
| Zeta Global Holdings Corp (Class A) | David A. Steinberg | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,554,739 | 5,079,500 | - | 0 | Class A Common Stock | |
| Doximity Inc (Class A) | Kevin Spain | Director | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 2,410,273 | 0 | - | 0 | Class A Common Stock | |
| Doximity Inc (Class A) | Kevin Spain | Director | 12 Feb 2025 | 2,410,273 | 2,410,273 | - | 0 | Class A Common Stock | ||
| Doximity Inc (Class A) | Kevin Spain | Director | 12 Feb 2025 | 2,410,273 | 2,410,273 | - | - | Class B Common Stock | ||
| X4 Pharma Inc | Paula S. Ragan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,250,000 | 3,337,386 (20%) | 13% | 0 | Common Stock | |
| Zeta Global Holdings Corp (Class A) | David A. Steinberg | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,343,850 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Zeta Global Holdings Corp (Class A) | Steven Gerber | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,169,151 | 2,829,867 | - | 0 | Class A Common Stock | |
| Zeta Global Holdings Corp (Class A) | Christopher E. Greiner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,021,819 | 2,020,876 | - | 0 | Class A Common Stock | |
| Hamilton Lane Inc (Class A) | Mario L. Giannini | Director, Executive Co-Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 1,000,000 | 1,312,331 | - | 0.0 | 1,000 | Class B Common Stock |
| Hamilton Lane Inc (Class A) | Mario L. Giannini | Director, Executive Co-Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 1,000,000 | 1,312,331 | - | - | Class B Units | |
| X4 Pharma Inc | Adam S. Mostafa | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 850,000 | 850,000 (5%) | 5% | 0 | Common Stock | |
| X4 Pharma Inc | Christophe Arbet-Engels | Chief Medical Officer | 12 Feb 2025 | 850,000 | 864,207 (5%) | 5% | 0 | Common Stock | ||
| X4 Pharma Inc | Mary DiBiase | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 650,000 | 1,140,980 (7%) | 4% | 0 | Common Stock | |
| Zeta Global Holdings Corp (Class A) | Steven Gerber | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 615,000 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Zeta Global Holdings Corp (Class A) | Christopher E. Greiner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 537,500 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Candel Therapeutics Inc | Paul Peter Tak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) | |
| Amentum Holdings Inc | Steven J. Demetriou | Director, Executive Chair | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 520,893 | 520,893 | - | - | Common Stock | |
| Niagen Bioscience Inc | Robert N. Fried | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 492,278 | 492,278 | - | - | Employee Stock Options (right to buy) | |
| Brookdale Senior Living Inc | Lucinda M. Baier | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 470,810 | 3,647,331 (1%) | 0% | 0 | Common Stock | |
| Charles Schwab | Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 464,629 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles Schwab | Walter W. Bettinger | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.39 per share. | 12 Feb 2025 | 464,629 | 1,292,006 (0%) | 0% | 26.4 | 12,261,559 | Common Stock |
| Charles Schwab | Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.87 per share. | 12 Feb 2025 | 441,797 | 850,209 (0%) | 0% | 81.9 | 36,170,406 | Common Stock |
| Montana Tech Corp (Class A) | Patrick C. Eilers | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 368,112 | 368,112 | - | - | Performance Restricted Stock Units | |
| Comstock Resources Inc | Miles Jay Allison | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 303,265 | 2,637,925 (1%) | 0% | 0 | Common Stock | |
| Roivant Sciences Ltd | Eric Venker | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 300,000 | 11,026,234 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 300,000 | 11,326,234 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 12 Feb 2025 | 300,000 | 1,032,294 | - | 3.9 | 1,155,000 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 12 Feb 2025 | 300,000 | 1,114,910 | - | 3.9 | 1,155,000 | Common Shares |
| Brookdale Senior Living Inc | Lucinda M. Baier | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 257,045 | 3,176,521 (1%) | 0% | 0 | Common Stock | |
| Mannkind Corp | Dominic Marasco | Pres, Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 252,000 | 252,000 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| CompoSecure Inc (Class A) | Thomas R. Knott | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.01 per share. | 12 Feb 2025 | 221,186 | 221,186 | - | 15.0 | 3,320,002 | Class A Common Stock |
| CompoSecure Inc (Class A) | John D. Cote | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.01 per share. | 12 Feb 2025 | 221,186 | 221,186 | - | 15.0 | 3,320,002 | Class A Common Stock |
| CompoSecure Inc (Class A) | Thomas R. Knott | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.50 per share. | 12 Feb 2025 | 220,587 | 441,773 | - | 15.5 | 3,419,099 | Class A Common Stock |
| CompoSecure Inc (Class A) | John D. Cote | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.50 per share. | 12 Feb 2025 | 220,587 | 441,773 | - | 15.5 | 3,419,099 | Class A Common Stock |
| Roivant Sciences Ltd | Eric Venker | President & COO | Sale of securities on an exchange or to another person at price $ 10.42 per share. | 12 Feb 2025 | 218,041 | 896,869 | - | 10.4 | 2,271,987 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & COO | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 12 Feb 2025 | 217,384 | 732,294 | - | 10.5 | 2,289,054 | Common Shares |
| 3M | William M. Brown | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 211,902 | 211,902 | - | - | Non-qualified Stock Option (Right to Buy) | |
| CompoSecure Inc (Class A) | Thomas R. Knott | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.83 per share. | 12 Feb 2025 | 205,120 | 646,893 | - | 15.8 | 3,247,050 | Class A Common Stock |
| CompoSecure Inc (Class A) | John D. Cote | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.83 per share. | 12 Feb 2025 | 205,120 | 646,893 | - | 15.8 | 3,247,050 | Class A Common Stock |
| DraftKings Inc (Class A) | Jason D. Robins | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 12 Feb 2025 | 200,000 | 2,678,613 | - | 45 | 9,000,000 | Class A Common Stock |
| DraftKings Inc (Class A) | Jason D. Robins | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 200,000 | 53 | - | - | Stock Option | |
| DraftKings Inc (Class A) | Jason D. Robins | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. | 12 Feb 2025 | 200,000 | 2,878,613 | - | 0.6 | 126,000 | Class A Common Stock |
| Meridian Holdings Inc | Aleksandar Milovanovic | Ten Percent Owner, Member of 10% Reporting Group | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 12 Feb 2025 | 200,000 | 78,214,616 | - | 1.9 | 370,000 | Common Stock |
| Doximity Inc (Class A) | Kevin Spain | Director | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 193,750 | 387,500 | - | 0 | Class A Common Stock | |
| Airbnb | Brian Chesky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 140.50 per share. | 12 Feb 2025 | 188,197 | 12,233,789 | - | 140.5 | 26,442,243 | Class A Common Stock |
| Pegasystems Inc | Alan Trefler | Director, C.E.O. & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 181,227 | 241,636 | - | - | Stock Options | |
| Charles Schwab | Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 12 Feb 2025 | 180,506 | 0 (0%) | 0% | 30.2 | 5,445,866 | Common Stock |
| Charles Schwab | Charles R. Schwab | Director, Co-Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 180,506 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Charles Schwab | Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 82.09 per share. | 12 Feb 2025 | 180,506 | 60,540,223 (4%) | 0% | 82.1 | 14,816,907 | Common Stock |
| Teva- pharma Ind Ltd (ADR) | Mark Sabag | See "Remarks" | Sale of securities on an exchange or to another person at price $ 16.25 per share. | 12 Feb 2025 | 177,626 | 204,964 (0%) | 0% | 16.3 | 2,886,565 | Ordinary Shares |
| Mondelez (Class A) | Dirk Van de Put | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 176,810 | 1,218,128 (0%) | 0% | 0 | Class A Common Stock | |
| Wabash National Corp | Brent L. Yeagy | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 174,051 | 578,063 (1%) | 0% | 0 | Common Stock | |
| Tractor Supply | Harry A. Lawton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 172,905 | 172,905 | - | - | Employee stock option | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 12 Feb 2025 | 171,813 | 90,983 (0%) | 0% | 32.7 | 5,616,808 | Ordinary Shares |
| Essent Grp Ltd | Mark A. Casale | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 57.11 per share. | 12 Feb 2025 | 157,591 | 2,315,942 (2%) | 0% | 57.1 | 9,000,022 | Common shares, par value $0.015 |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 12 Feb 2025 | 146,338 | 3,183,380 (4%) | 0% | 11.1 | 1,626,196 | Common Stock |
| Brookdale Senior Living Inc | Dawn L. Kussow | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 141,988 | 426,042 (0%) | 0% | 0 | Common Stock | |
| Hamilton Lane Inc (Class A) | Hartley R. Rogers | Director, Executive Co-Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 139,745 | 6,760,922 | - | 0.0 | 140 | Class B Common Stock |
| Hamilton Lane Inc (Class A) | Hartley R. Rogers | Director, Executive Co-Chairman, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 139,745 | 6,760,922 | - | - | Class B Units | |
| Resideo Tech Inc | Thomas A. Surran | President Products & Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 138,185 | 266,760 (0%) | 0% | 0 | Common Stock | |
| Gilead Sciences | Andrew D. Dickinson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 102.22 per share. | 12 Feb 2025 | 137,676 | 171,223 (0%) | 0% | 102.2 | 14,073,241 | Common Stock |
| McDonald's | Christopher J. Kempczinski | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 119,959 | 119,959 | - | - | Options (Right to Buy) | |
| Asana Inc (Class A) | Justin Rosenstein | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.62 per share. | 12 Feb 2025 | 116,325 | 1,447,309 | - | 22.6 | 2,631,272 | Class A Common Stock |
| NMI Holdings Inc (Class A) | Adam S. Pollitzer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 116,144 | 445,609 (0%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Teradata Corp | Steve McMillan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 114,262 | 487,841 (0%) | 0% | 0 | Common Stock | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 113,652 | 113,652 | - | - | Performance Stock Units | |
| Occidental Petroleum | Vicki A. Hollub | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 113,426 | 938,557 (0%) | 0% | 0 | Common Stock | |
| Charles Schwab | Charles R. Schwab | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 81.20 per share. | 12 Feb 2025 | 113,051 | 60,427,172 (4%) | 0% | 81.2 | 9,179,357 | Common Stock |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.34 per share. | 12 Feb 2025 | 111,630 | 262,796 (0%) | 0% | 19.3 | 2,158,924 | Ordinary Shares |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 111,630 | 50,104 | - | - | Employee Stock Option (Right to Buy) | |
| Alight Inc (Class A) | Dinesh V. Tulsiani | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 110,131 | 857,268 | - | 0 | Class A Common Stock | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 108,833 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.02 per share. | 12 Feb 2025 | 108,833 | 57,875 (0%) | 0% | 36.0 | 3,920,001 | Ordinary Shares |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.93 per share. | 12 Feb 2025 | 108,833 | 166,708 (0%) | 0% | 31.9 | 3,475,038 | Ordinary Shares |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 107,250 | 107,250 | - | - | Stock Option (Right to Buy) | |
| Neurocrine Biosciences Inc | Kyle W. Gano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 104,736 | 104,736 | - | - | Stock Option | |
| Cooper-Standard Holdings Inc | Jeffrey S. Edwards | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 103,756 | 0 | - | - | Performance Stock Units | |
| Cooper-Standard Holdings Inc | Jeffrey S. Edwards | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 103,756 | 325,893 (1%) | 0% | - | Common stock | |
| Cooper-Standard Holdings Inc | Jeffrey S. Edwards | Director, Chairman and CEO | Sale or transfer of securities back to the company at price $ 14.41 per share. | 12 Feb 2025 | 103,756 | 222,137 (1%) | 0% | 14.4 | 1,495,124 | Common stock |
| Magnolia Oil & Gas Corp (Class A) | Christopher G. Stavros | Director, CEO & DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,684 | 962,526 (0%) | 0% | 0 | Class A Common Stock | |
| Magnolia Oil & Gas Corp (Class A) | Christopher G. Stavros | Director, CEO & DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,684 | 100,684 | - | - | Performance Share Units | |
| Cooper-Standard Holdings Inc | Jeffrey S. Edwards | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,132 | 100,132 | - | - | Restricted Stock Units | |
| Amentum Holdings Inc | Steven J. Demetriou | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 20.81 per share. | 12 Feb 2025 | 100,000 | 620,893 | - | 20.8 | 2,080,700 | Common Stock |
| DoorDash | Andy Fang | Director | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 6,339,604 | - | - | Class B Common Stock | |
| DoorDash | Andy Fang | Director | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 100,000 | - | 0 | Class A Common Stock | |
| DoorDash | Andy Fang | Director | Sale of securities on an exchange or to another person at price $ 200.11 per share. | 12 Feb 2025 | 100,000 | 0 | - | 200.1 | 20,010,800 | Class A Common Stock |
| Meridian Holdings Inc | Aleksandar Milovanovic | Ten Percent Owner, Member of 10% Reporting Group | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 12 Feb 2025 | 100,000 | 78,314,616 | - | 1.9 | 185,000 | Common Stock |
| Hamilton Lane Inc (Class A) | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 625,005 | - | 0.0 | 100 | Class B Common Stock |
| Hamilton Lane Inc (Class A) | Michael Schmertzler | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 625,005 | - | - | Class B Units | |
| Medicinova Inc | Yuichi Iwaki | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 96,155 | 96,155 | - | - | Performance Stock Units | |
| Enovix Corp | Rajendra K. Talluri | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 95,551 | 2,362,918 | - | 0 | Common Stock | |
| Repay Holdings Corp (Class A) | John Andrew Morris | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 93,871 | 1,007,981 (2%) | 0% | 0 | Class A Common Stock | |
| Comstock Resources Inc | Roland O. Burns | Director, President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 92,135 | 1,386,850 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 91,399 | 461,777 (3%) | 0% | 0 | Common Stock | |
| Montana Tech Corp (Class A) | Matthew Jore B. | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 90,405 | 90,405 | - | - | Restricted Stock Units | |
| Laureate Education Inc | Eilif Serck-Hanssen | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 88,117 | 1,174,640 | - | 0 | Common Stock | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 87,566 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.03 per share. | 12 Feb 2025 | 87,566 | 151,166 (0%) | 0% | 20.0 | 1,753,947 | Ordinary Shares |
| Lumen Tech Inc | David D. Ward | EVP, Chief Tech & Prod Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. | 12 Feb 2025 | 87,376 | 1,458,025 (0%) | 0% | 4.7 | 407,172 | Common Stock |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.02 per share. | 12 Feb 2025 | 84,948 | 5,208,057 | - | 70.0 | 5,948,059 | Class A Common Stock |
| Asana Inc (Class A) | Justin Rosenstein | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.99 per share. | 12 Feb 2025 | 83,675 | 1,563,634 | - | 22.0 | 1,840,013 | Class A Common Stock |
| Candel Therapeutics Inc | Charles Schoch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 83,000 | 83,000 | - | - | Stock Option (Right to Buy) | |
| Gilead Sciences | Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 77,691 | 17,929 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.91 per share. | 12 Feb 2025 | 77,691 | 248,914 (0%) | 0% | 63.9 | 4,965,232 | Common Stock |
| Citizens Financial Group | Bruce Winfield Van Saun | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 76,720 | 1,224,542 (0%) | 0% | 0 | Common Stock | |
| Virtu Fin Inc (Class A) | Brett Fairclough | Co-President & Co-COO | Sale of securities on an exchange or to another person at price $ 36.84 per share. | 12 Feb 2025 | 72,967 | 90,749 (0%) | 0% | 36.8 | 2,688,440 | Class A common stock |
| Aris Water Soln Inc (Class A) | Amanda M. Brock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 72,709 | 494,682 | - | 0 | Class A Common Stock | |
| Brookdale Senior Living Inc | Chad C. White | EVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 72,516 | 542,933 (0%) | 0% | 0 | Common Stock | |
| NMI Holdings Inc (Class A) | Adam S. Pollitzer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 72,098 | 329,465 | - | 0 | Restricted Stock Unit (right to receive) | |
| CenterPoint Energy | Jason P. Wells | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 70,212 | 344,729 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | James E. Davis | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 69,633 | 69,633 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Mondelez (Class A) | Dirk Van de Put | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.60 per share. | 12 Feb 2025 | 69,273 | 1,148,855 (0%) | 0% | 60.6 | 4,197,944 | Class A Common Stock |
| Occidental Petroleum | Vicki A. Hollub | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 68,989 | 1,007,546 (0%) | 0% | 0 | Common Stock | |
| Laureate Education Inc | Eilif Serck-Hanssen | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 68,966 | 1,243,606 | - | 0 | Common Stock | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 68,921 | 68,921 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 68,921 | 30,963,149 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 68,921 | 30,963,149 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 68,921 | 68,921 (0%) | 0% | 0 | Class A Common Stock | ||
| Occidental Petroleum | Vicki A. Hollub | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.83 per share. | 12 Feb 2025 | 68,646 | 938,900 (0%) | 0% | 47.8 | 3,283,338 | Common Stock |
| Federal Realty - REIT | Donald C. Wood | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 68,335 | 193,115 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 67,687 | 122,243 | - | - | Stock Option (right to buy) | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.40 per share. | 12 Feb 2025 | 67,687 | 774,559 | - | 0.4 | 27,075 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 67,118 | 30,896,031 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 67,118 | 67,118 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 67,118 | 30,896,031 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 67,118 | 67,118 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.91 per share. | 12 Feb 2025 | 67,057 | 61 (0%) | 0% | 30.9 | 2,072,732 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.91 per share. | 12 Feb 2025 | 67,057 | 61 (0%) | 0% | 30.9 | 2,072,732 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 65,722 | 65,722 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 65,722 | 31,032,070 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 65,722 | 65,722 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 12 Feb 2025 | 65,722 | 31,032,070 | - | - | Class B Common Stock | ||
| Regency Centers - REIT | Lisa Palmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 65,301 | 195,302 (0%) | 0% | - | Common Stock | |
| Candel Therapeutics Inc | Seshu Tyagarajan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Pilgrims Pride Corp | Fabio Sandri | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 63,057 | 360,930 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Portland General Electric Co | Maria M. Pope | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 41.85 per share. | 12 Feb 2025 | 63,021 | 254,178 (0%) | 0% | 41.9 | 2,637,429 | Common Stock |
| Marcus Corp | Gregory S. Marcus | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 62,440 | 528,039 (2%) | 0% | 0 | Common Stock | |
| Ceva Inc | Amir Panush | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 62,170 | 158,576 (0%) | 0% | 0 | Common Stock | |
| Teradata Corp | Steve McMillan | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.62 per share. | 12 Feb 2025 | 61,097 | 426,744 (0%) | 0% | 24.6 | 1,504,208 | Common Stock |
| ANI Pharma Inc | Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 60,932 | 522,709 (4%) | 0% | 0 | Common Stock | |
| Amcor | Arun Nayar | Director | Purchase of securities on an exchange or from another person at price $ 9.95 per share. | 12 Feb 2025 | 59,000 | 135,191 (0%) | 0% | 10.0 | 587,050 | Ordinary Shares |
| NMI Holdings Inc (Class A) | Adam S. Pollitzer | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Feb 2025 | 58,978 | 386,631 (0%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| Mondelez (Class A) | Luca Zaramella | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 58,941 | 369,637 (0%) | 0% | 0 | Class A Common Stock | |
| Regency Centers - REIT | Lisa Palmer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 57,983 | 27,634 | - | - | Restricted Stock | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 56,825 | 56,825 | - | - | Restricted Stock Units | |
| Montana Tech Corp (Class A) | Matthew Jore B. | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 55,748 | 55,748 | - | - | Performance Restricted Stock Units | |
| Aris Water Soln Inc (Class A) | William A. Zartler | Director, Founder and Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 54,935 | 558,589 | - | 0 | Class A Common Stock | |
| Truist Financial | Kristin Lesher | Chief Whlse Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 54,831 | 54,831 (0%) | 0% | 0 | Common Stock | |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 54,708 | 647,718 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences Inc | Jude Onyia | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 54,645 | 54,645 | - | - | Stock Option | |
| Wabash National Corp | Michael N. Pettit | SVP and Chief Growth Officer | 12 Feb 2025 | 53,402 | 170,629 (0%) | 0% | 0 | Common Stock | ||
| Altice USA Inc (Class A) | Susan C. Schnabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 53,381 | 183,697 (0%) | 0% | - | Class A common stock | |
| Altice USA Inc (Class A) | Raymond Svider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 53,381 | 222,697 (0%) | 0% | - | Class A common stock | |
| Altice USA Inc (Class A) | Mark Mullen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 53,381 | 163,697 (0%) | 0% | - | Class A common stock | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.53 per share. | 12 Feb 2025 | 52,893 | 16,028 (0%) | 0% | 31.5 | 1,667,716 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.53 per share. | 12 Feb 2025 | 52,893 | 16,028 (0%) | 0% | 31.5 | 1,667,716 | Class A Common Stock |
| HNI Corp | Jeffrey D. Lorenger | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 52,792 | 349,684 (0%) | 0% | 0 | Common Stock | |
| Montana Tech Corp (Class A) | Stephen S. Pang | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 52,736 | 52,736 | - | - | Restricted Stock Units | |
| Vital Farms Inc | Russell Diez-Canseco | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.33 per share. | 12 Feb 2025 | 52,500 | 720,702 | - | 5.3 | 279,752 | Common Stock |
| Vital Farms Inc | Russell Diez-Canseco | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 52,500 | 144,448 | - | - | Employee Stock Option (right to buy) | |
| Brookdale Senior Living Inc | H. Todd Kaestner | EVP-Corp Dev & Pres-CCRCs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 52,232 | 405,020 (0%) | 0% | 0 | Common Stock | |
| Resideo Tech Inc | Thomas A. Surran | President Products & Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 50,667 | 128,575 (0%) | 0% | 0 | Common Stock | |
| Resideo Tech Inc | Robert B. Aarnes | President, ADI | 12 Feb 2025 | 50,667 | 511,274 (0%) | 0% | 0 | Common Stock | ||
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 50,158 | 0 | - | - | Performance Stock Units | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 50,158 | 786,117 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| DoorDash | Andy Fang | Director | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 50,000 | 6,289,604 | - | - | Class B Common Stock | |
| DoorDash | Andy Fang | Director | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 50,000 | 50,000 | - | 0 | Class A Common Stock | |
| Lazard Ltd (Class A) | Evan L. Russo | CEO of Asset Management | 12 Feb 2025 | 50,000 | 34,336 (0%) | 0% | 53.4 | 2,670,175 | Common Stock | |
| Marker Therapeutics Inc | Juan Vera | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Alight Inc (Class A) | Dinesh V. Tulsiani | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 12 Feb 2025 | 49,865 | 807,403 | - | 6.6 | 331,104 | Class A Common Stock |
| Cooper-Standard Holdings Inc | Jeffrey S. Edwards | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 49,024 | 49,024 | - | - | Performance Stock Units | |
| Comstock Resources Inc | Daniel S. Harrison | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 48,666 | 762,007 (0%) | 0% | 0 | Common Stock | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.38 per share. | 12 Feb 2025 | 47,489 | 0 (0%) | 0% | 30.4 | 1,442,716 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.38 per share. | 12 Feb 2025 | 47,489 | 0 (0%) | 0% | 30.4 | 1,442,716 | Class A Common Stock |
| Avista Corp | Heather Lynn Rosentrater | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 46,717 | 46,717 | - | - | Performance Shares Grant - 2025 | |
| Ritchie Bros Auctioneers Inc | James Francis Kessler | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 46,489 | 46,489 | - | - | Restricted Share Units (2025 RSUs) | |
| Resideo Tech Inc | Michael Carlet | Chief Financial Officer | 12 Feb 2025 | 46,061 | 181,400 (0%) | 0% | 0 | Common Stock | ||
| MDU Resources Grp Inc | Nicole A. Kivisto | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 45,969 | 568,409 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences Inc | Matthew C. Abernethy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 45,538 | 45,538 | - | - | Stock Option | |
| Apollo Global (Class A) (New) | John Zito | Co-President (see Remarks) | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.75 per share. | 12 Feb 2025 | 45,041 | 3,007,058 (1%) | 0% | 165.8 | 7,465,546 | Common Stock |
| Enanta Pharma Inc | Jay R. Luly | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 12 Feb 2025 | 45,000 | 846,638 (4%) | 0% | 5.7 | 256,050 | Common Stock |
| Vital Farms Inc | Russell Diez-Canseco | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 35.27 per share. | 12 Feb 2025 | 44,970 | 675,732 | - | 35.3 | 1,586,092 | Common Stock |
| Manhattan Associates Inc | Eric Andrew Clark | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 43,969 | 43,969 (0%) | 0% | 0 | Common Stock | |
| Tractor Supply | Harry A. Lawton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 43,642 | 531,319 (0%) | 0% | 0 | Common stock | |
| Neurocrine Biosciences Inc | Eiry W. Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 43,261 | 43,261 | - | - | Stock Option | |
| NMI Holdings Inc (Class A) | William J. Leatherberry | Chief Admin. Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 43,252 | 198,871 (0%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| Neurocrine Biosciences Inc | Eric S. Benevich | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 42,805 | 42,805 | - | - | Stock Option | |
| Occidental Petroleum | Jeff F. Simmons | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 42,455 | 319,154 (0%) | 0% | 0 | Common Stock | |
| Montana Tech Corp (Class A) | Jeffrey Gutke D. | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 42,189 | 42,189 | - | - | Restricted Stock Units | |
| Edesa Biotech Inc | Patrick Marshall | Director | Grant, award, or other acquisition of securities at price $ 1.92 per share. | 12 Feb 2025 | 41,666 | 41,666 (0%) | 0% | 1.9 | 79,999 | Common Shares |
| Mondelez (Class A) | Vinzenz P. Gruber | EVP and President, Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 41,263 | 324,096 (0%) | 0% | 0 | Class A Common Stock | |
| McDonald's | Ian Frederick Borden | EVP - CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 41,236 | 41,236 | - | - | Options (Right to Buy) | |
| Occidental Petroleum | Sunil Mathew | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 41,039 | 207,374 (0%) | 0% | 0 | Common Stock | |
| Occidental Petroleum | Kenneth Dillon | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 40,718 | 322,922 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences Inc | Darin M. Lippoldt | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 38,252 | 38,252 | - | - | Stock Option | |
| Brookdale Senior Living Inc | Benjamin J. Ricci | Division Vice President | 12 Feb 2025 | 38,033 | 187,832 (0%) | 0% | 0 | Common Stock | ||
| Brookdale Senior Living Inc | Ray Leisure M. | Division Vice President | 12 Feb 2025 | 38,033 | 90,658 (0%) | 0% | 0 | Common Stock | ||
| Montana Tech Corp (Class A) | Patrick C. Eilers | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 37,669 | 37,669 | - | - | Restricted Stock Units | |
| Occidental Petroleum | Robert L. Peterson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 37,228 | 270,695 (0%) | 0% | 0 | Common Stock | |
| Occidental Petroleum | Richard A. Jackson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 37,228 | 246,681 (0%) | 0% | 0 | Common Stock | |
| Cbiz Inc | Jerome P. Grisko | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 36,884 | 206,542 (0%) | 0% | 0 | Common Stock | |
| Apollo Global (Class A) (New) | Martin Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.75 per share. | 12 Feb 2025 | 36,604 | 382,164 (0%) | 0% | 165.8 | 6,067,113 | Common Stock |
| Magnolia Oil & Gas Corp (Class A) | Timothy D. Yang | EVP - GENERAL COUNSEL & SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 36,246 | 675,441 (0%) | 0% | 0 | Class A Common Stock | |
| Magnolia Oil & Gas Corp (Class A) | Timothy D. Yang | EVP - GENERAL COUNSEL & SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 36,246 | 36,246 | - | - | Performance Share Units | |
| Magnolia Oil & Gas Corp (Class A) | Brian M. Corales | SVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 36,246 | 199,825 (0%) | 0% | 0 | Class A Common Stock | |
| Magnolia Oil & Gas Corp (Class A) | Brian M. Corales | SVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 36,246 | 36,246 | - | - | Performance Share Units | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.02 per share. | 12 Feb 2025 | 35,586 | 166,708 (0%) | 0% | 34.0 | 1,210,696 | Ordinary Shares |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.59 per share. | 12 Feb 2025 | 35,586 | 202,294 (0%) | 0% | 24.6 | 875,060 | Ordinary Shares |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 35,586 | 71,172 | - | - | Employee Stock Option (Right to Buy) | |
| Tractor Supply | Kurt D. Barton | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 35,515 | 35,515 | - | - | Employee stock option | |
| Apollo Global (Class A) (New) | James C. Zelter | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.75 per share. | 12 Feb 2025 | 35,198 | 5,058,164 (2%) | 0% | 165.8 | 5,834,069 | Common Stock |
| Lazard Ltd (Class A) | Evan L. Russo | CEO of Asset Management | 12 Feb 2025 | 35,000 | 188,448 (0%) | 0% | 53.6 | 1,877,250 | Common Stock | |
| Resideo Tech Inc | Jeannine J. Lane | EVP, GC and Corp Sec | 12 Feb 2025 | 34,546 | 159,742 (0%) | 0% | 0 | Common Stock | ||
| Vodafone Grp PLC (ADR) | Jean-Francois M.L. van Boxmeer | Non-Executive Director,Chairman | Sale or transfer of securities back to the company at price $ 0.69 per share. | 12 Feb 2025 | 34,232 | 1,306,097 (0%) | 0% | 0.7 | 23,620 | Ords 1.15p |
| Neurocrine Biosciences Inc | David W. Boyer | Chief Corp. Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 34,153 | 34,153 | - | - | Stock Option | |
| Neurocrine Biosciences Inc | Ingrid Delaet | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 34,153 | 34,153 | - | - | Stock Option | |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 84.70 per share. | 12 Feb 2025 | 33,914 | 5,095,549 | - | 84.7 | 2,872,516 | Class A Common Stock |
| Wabash National Corp | Mary Kristin Glazner | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 33,624 | 140,476 (0%) | 0% | 0 | Common Stock | |
| Cooper-Standard Holdings Inc | Jeffrey S. Edwards | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 33,613 | 231,936 (1%) | 0% | 0 | Common stock | |
| Kingsway Corp | Joseph D. Stilwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 33,600 | 33,600 | - | - | Class C Preferred Stock | |
| Byrna Tech Inc | Luan Pham | Chief Mktg and Rev Officer | Sale of securities on an exchange or to another person at price $ 30.19 per share. | 12 Feb 2025 | 33,483 | 19,148 | - | 30.2 | 1,010,905 | Common Stock |
| Arq Inc | Joseph M. Wong | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 33,420 | 0 | - | - | Performance Share Unit | |
| Brookdale Senior Living Inc | Chad C. White | EVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 33,417 | 576,350 (0%) | 0% | 0 | Common Stock | |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 33,356 | 681,074 (0%) | 0% | 0 | Common Stock | |
| Portland General Electric Co | Maria M. Pope | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 41.85 per share. | 12 Feb 2025 | 33,328 | 191,157 (0%) | 0% | 41.9 | 1,394,777 | Common Stock |
| Enovix Corp | Ajay Marathe | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 33,170 | 1,084,077 | - | 0 | Common Stock | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.27 per share. | 12 Feb 2025 | 33,108 | 57,875 (0%) | 0% | 33.3 | 1,101,470 | Ordinary Shares |
| NMI Holdings Inc (Class A) | Robert Smith | EVP, Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 33,100 | 121,375 (0%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| Amcor | Arun Nayar | Director | Purchase of securities on an exchange or from another person at price $ 9.95 per share. | 12 Feb 2025 | 33,000 | 33,000 (0%) | 0% | 10.0 | 328,350 | Ordinary Shares |
| Element Soln Inc | Carey James Dorman | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 32,934 | 32,934 | - | - | Performance Stock Units | |
| Pilgrims Pride Corp | Matthew R. Galvanoni | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 32,790 | 79,057 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| 3M | Anurag Maheshwari | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 32,542 | 32,542 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Brookdale Senior Living Inc | Frank M. Bumstead | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 32,454 | 532,506 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Lee S. Wielansky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 32,454 | 243,836 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Victoria L. Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 32,454 | 169,716 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Denise W. Warren | Director | 12 Feb 2025 | 32,454 | 201,104 (0%) | 0% | 0 | Common Stock | ||
| Brookdale Senior Living Inc | Jordan R. Asher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 32,454 | 139,633 (0%) | 0% | 0 | Common Stock | |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 86.87 per share. | 12 Feb 2025 | 32,200 | 5,051,760 | - | 86.9 | 2,797,214 | Class A Common Stock |
| Essent Grp Ltd | Mark A. Casale | Director, Chairman, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2025 | 32,055 | 2,283,887 (2%) | 0% | 0 | Common shares, par value $0.015 | |
| Teradata Corp | Claire Bramley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 31,994 | 178,339 (0%) | 0% | 0 | Common Stock | |
| Ritchie Bros Auctioneers Inc | James Francis Kessler | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 31,750 | 0 | - | - | Performance Share Units (2022 PSUs) | |
| Ritchie Bros Auctioneers Inc | James Francis Kessler | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 31,750 | 31,750 | - | - | Performance Share Units (2022 PSUs) | |
| Ritchie Bros Auctioneers Inc | James Francis Kessler | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 31,750 | 117,997 (0%) | 0% | - | Common Shares | |
| Pegasystems Inc | Kenneth Stillwell | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 31,326 | 31,326 | - | - | Stock Options | |
| Mondelez (Class A) | Gustavo Carlos Valle | EVP and President, NA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,950 | 75,410 (0%) | 0% | 0 | Class A Common Stock | |
| MDU Resources Grp Inc | Jason L. Vollmer | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.83 per share. | 12 Feb 2025 | 30,429 | 332,689 (0%) | 0% | 16.8 | 512,120 | Common Stock |
| Brookdale Senior Living Inc | George T. Hicks | EVP & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,426 | 382,309 (0%) | 0% | 0 | Common Stock | |
| MDU Resources Grp Inc | Nicole A. Kivisto | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.83 per share. | 12 Feb 2025 | 30,316 | 538,093 (0%) | 0% | 16.8 | 510,218 | Common Stock |
| Halozyme Therapeutics Inc | Mark Snyder | SVP, CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,050 | 30,050 | - | - | Performance Stock Units | |
| Lightbridge Corp | Andrey Mushakov | EVP, Nuclear Operations | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Feb 2025 | 30,000 | 159,893 (4%) | 0% | 14.6 | 437,400 | Common Stock |
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Marker Therapeutics Inc | Steven A. Elms | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Marker Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Pegasystems Inc | Kenneth Stillwell | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,000 | 30,000 | - | - | Stock Options | |
| McDonald's | Joseph Erlinger | President, McDonalds USA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 29,990 | 29,990 | - | - | Options (Right to Buy) | |
| Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 29,761 | 803,821 | - | 0 | Common Stock | |
| Joby Aviation Inc | JoeBen Bevirt | Director, CEO and Chief Architect, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 29,761 | 59,524 | - | - | Restricted Stock Units (RSUs) | |
| Wabash National Corp | Donald Winston | SVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 29,668 | 48,128 (0%) | 0% | 0 | Common Stock | |
| Murphy USA Inc | R. Andrew Clyde | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 29,608 | 233,670 (0%) | 0% | 0 | Common Stock | |
| Neurocrine Biosciences Inc | Julie S. Cooke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 29,600 | 29,600 | - | - | Stock Option | |
| Apollo Global (Class A) (New) | Whitney Chatterjee | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.75 per share. | 12 Feb 2025 | 29,548 | 87,692 (0%) | 0% | 165.8 | 4,897,581 | Common Stock |
| Portland General Electric Co | Maria M. Pope | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.85 per share. | 12 Feb 2025 | 28,892 | 225,286 (0%) | 0% | 41.8 | 1,209,130 | Common Stock |
| Repay Holdings Corp (Class A) | John Andrew Morris | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. | 12 Feb 2025 | 28,886 | 979,095 (2%) | 0% | 7.2 | 207,690 | Class A Common Stock |
| Halozyme Therapeutics Inc | Nicole LaBrosse | SVP, CHIEF FINANCIAL OFFICER | 12 Feb 2025 | 28,662 | 28,662 | - | - | Performance Stock Units | ||
| Joby Aviation Inc | Didier Papadopoulos | President of Aircraft OEM | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 28,571 | 57,143 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Didier Papadopoulos | President of Aircraft OEM | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 28,571 | 81,406 | - | 0 | Common Stock | |
| Bellring Brands Inc | Robert V. Vitale | Director | Sale of securities on an exchange or to another person at price $ 76.91 per share. | 12 Feb 2025 | 28,453 | 1,110,004 (2%) | 0% | 76.9 | 2,188,320 | Common Stock |
| McDonald's | Gillian McDonald | EVP - President, IOM | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 28,116 | 28,116 | - | - | Options (Right to Buy) | |
| Citizens Financial Group | Donald H. McCree | Head of Commercial Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 27,895 | 198,461 (0%) | 0% | 0 | Common Stock | |
| Resideo Tech Inc | Stephen M. Kelly | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 27,637 | 229,585 (0%) | 0% | 0 | Common Stock | |
| Repay Holdings Corp (Class A) | Timothy John Murphy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 27,068 | 477,947 (1%) | 0% | 0 | Class A Common Stock | |
| Truist Financial | Kristin Lesher | Chief Whlse Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.38 per share. | 12 Feb 2025 | 26,735 | 28,096 (0%) | 0% | 46.4 | 1,239,969 | Common Stock |
| Comstock Resources Inc | Clifford Doyle Newell | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 26,545 | 97,225 (0%) | 0% | 0 | Common Stock | |
| Mondelez (Class A) | Laura Stein | EVP, CLA and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 26,531 | 84,327 (0%) | 0% | 0 | Class A Common Stock | |
| Amazon | Douglas J. Herrington | CEO Worldwide Amazon Stores | Sale of securities on an exchange or to another person at price $ 230.30 per share. | 12 Feb 2025 | 26,501 | 497,467 (0%) | 0% | 230.3 | 6,103,080 | Common Stock, par value $.01 per share |
| Citizens Financial Group | John F. Woods | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 26,324 | 351,365 (0%) | 0% | 0 | Common Stock | |
| Essent Grp Ltd | Mark A. Casale | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 57.11 per share. | 12 Feb 2025 | 26,266 | 2,158,351 (2%) | 0% | 57.1 | 1,500,051 | Common shares, par value $0.015 |
| Pegasystems Inc | Alan Trefler | Chief of Clients and Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 26,250 | 35,000 | - | - | Stock Options | |
| Pegasystems Inc | John Gerard Higgins | Chief, Client &Partner Success | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 26,250 | 35,000 | - | - | Stock Options | |
| Gilead Sciences | Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.92 per share. | 12 Feb 2025 | 26,175 | 275,089 (0%) | 0% | 57.9 | 1,516,056 | Common Stock |
| Gilead Sciences | Andrew D. Dickinson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 26,175 | 78,515 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Tractor Supply | Robert D. Mills | EVP Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 26,169 | 26,169 | - | - | Employee stock option | |
| Occidental Petroleum | Kenneth Dillon | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.83 per share. | 12 Feb 2025 | 25,846 | 321,842 (0%) | 0% | 47.8 | 1,236,214 | Common Stock |
| Cooper-Standard Holdings Inc | Jonathan P. Banas | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 25,692 | 25,692 | - | - | Restricted Stock Units | |
| Federal Realty - REIT | Donald C. Wood | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.55 per share. | 12 Feb 2025 | 25,675 | 167,440 (0%) | 0% | 110.5 | 2,838,371 | Common Shares of Beneficial Interest |
| Enanta Pharma Inc | Jay R. Luly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 25,500 | 872,138 (4%) | 0% | 0 | Common Stock | |
| Hamilton Lane Inc (Class A) | O. Griffith Sexton | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 25,000 | 291,233 | - | 0.0 | 25 | Class B Common Stock |
| Hamilton Lane Inc (Class A) | O. Griffith Sexton | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 25,000 | 291,233 | - | 0.0 | 25 | Class B Common Stock |
| Hamilton Lane Inc (Class A) | O. Griffith Sexton | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 25,000 | 291,233 | - | - | Class B Units | |
| Hamilton Lane Inc (Class A) | O. Griffith Sexton | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Feb 2025 | 25,000 | 291,233 | - | - | Class B Units | |
| Lazard Ltd (Class A) | Evan L. Russo | CEO of Asset Management | 12 Feb 2025 | 25,000 | 163,448 (0%) | 0% | 55.3 | 1,383,000 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,957 | 71,810 | - | - | Performance Stock Units | |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 78.51 per share. | 12 Feb 2025 | 24,896 | 5,157,795 | - | 78.5 | 1,954,585 | Class A Common Stock |
| Brookdale Senior Living Inc | Jaclyn C. Pritchett | EVP - Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,848 | 135,716 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,808 | 179,276 (1%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,808 | 101,585 (0%) | 0% | 0 | Common Stock | |
| Occidental Petroleum | Kenneth Dillon | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,766 | 347,688 (0%) | 0% | 0 | Common Stock | |
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,500 | 24,500 | - | - | Stock Option (Right to Buy) | |
| Medicinova Inc | Hideki Nagao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,500 | 24,500 | - | - | Stock Option (Right to Buy) | |
| Medicinova Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,500 | 24,500 | - | - | Stock Option (Right to Buy) | |
| Tractor Supply | Jonathan Seth Estep | EVP Chief Merchandise Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,300 | 24,300 | - | - | Employee stock option | |
| NMI Holdings Inc (Class A) | Bradley M. Shuster | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,175 | 431,337 | - | 0 | Restricted Stock Unit (right to receive) | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2025 | 24,078 | 114,469 (0%) | 0% | 0 | Common Stock | |
| Joby Aviation Inc | Bonny W. Simi | President of Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 23,809 | 47,619 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Bonny W. Simi | President of Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 23,809 | 163,066 | - | 0 | Common Stock | |
| Alight Inc (Class A) | Jeremy J. Heaton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,765 | 603,069 | - | 0 | Class A Common Stock | |
| 3M | Peter D. Gibbons | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,764 | 23,764 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M | Christian T. Goralski | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,764 | 23,764 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M | Wendy A. Bauer | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,764 | 23,764 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Wabash National Corp | Patrick Keslin | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,735 | 31,511 (0%) | 0% | 0 | Common Stock | |
| Mondelez (Class A) | Luca Zaramella | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.60 per share. | 12 Feb 2025 | 23,677 | 345,960 (0%) | 0% | 60.6 | 1,434,826 | Class A Common Stock |
| Occidental Petroleum | Robert L. Peterson | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.83 per share. | 12 Feb 2025 | 23,646 | 269,692 (0%) | 0% | 47.8 | 1,130,988 | Common Stock |
| Occidental Petroleum | Richard A. Jackson | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.83 per share. | 12 Feb 2025 | 23,643 | 245,681 (0%) | 0% | 47.8 | 1,130,845 | Common Stock |
| Regency Centers - REIT | Lisa Palmer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.89 per share. | 12 Feb 2025 | 23,587 | 171,715 (0%) | 0% | 70.9 | 1,672,082 | Common Stock |
| Mondelez (Class A) | Martin Renaud | EVP, Chief Mkting & Sales Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,584 | 82,574 (0%) | 0% | 0 | Class A Common Stock | |
| Aris Water Soln Inc (Class A) | Amanda M. Brock | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.06 per share. | 12 Feb 2025 | 23,432 | 471,250 | - | 28.1 | 657,502 | Class A Common Stock |
| Tempus AI Inc (Class A) | Eric P. Lefkofsky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 79.81 per share. | 12 Feb 2025 | 23,332 | 5,134,463 | - | 79.8 | 1,862,127 | Class A Common Stock |
| Tractor Supply | Harry A. Lawton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,317 | 496,852 (0%) | 0% | 0 | Common stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,260 | 23,260 | - | - | Performance Stock Unit | |
| Element Soln Inc | Matthew Liebowitz | EVP, Strategy and Head of I&S | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,248 | 23,248 | - | - | Performance Stock Units | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.35 per share. | 12 Feb 2025 | 23,172 | 735,746 | - | 44.3 | 1,027,597 | Class A Common Stock |
| Brookdale Senior Living Inc | H. Todd Kaestner | EVP-Corp Dev & Pres-CCRCs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 23,134 | 428,154 (0%) | 0% | 0 | Common Stock | |
| Avista Corp | Heather Lynn Rosentrater | President & CEO | Grant, award, or other acquisition of securities at price $ 36.98 per share. | 12 Feb 2025 | 22,916 | 56,342 | - | 37.0 | 847,434 | Common Stock - Restricted Shares Grant 2025 |
| Charles Schwab | Walter W. Bettinger | Director, Co-Chairman | Sale of securities on an exchange or to another person at price $ 82.66 per share. | 12 Feb 2025 | 22,832 | 827,377 (0%) | 0% | 82.7 | 1,887,186 | Common Stock |
| Essent Grp Ltd | Christopher G. Curran | Pres., Essent Guaranty, Inc. | Grant, award, or other acquisition of securities at price $ 57.11 per share. | 12 Feb 2025 | 22,764 | 308,698 (0%) | 0% | 57.1 | 1,300,052 | Common shares, par value $0.015 |
| Occidental Petroleum | Robert L. Peterson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 22,643 | 293,338 (0%) | 0% | 0 | Common Stock | |
| Occidental Petroleum | Richard A. Jackson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 22,643 | 269,324 (0%) | 0% | 0 | Common Stock | |
| Cooper-Standard Holdings Inc | Jonathan P. Banas | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 22,526 | 0 | - | - | Performance Stock Units | |
| Cooper-Standard Holdings Inc | Jonathan P. Banas | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 22,526 | 47,575 (0%) | 0% | - | Common stock | |
| Cooper-Standard Holdings Inc | Jonathan P. Banas | EVP and CFO | Sale or transfer of securities back to the company at price $ 14.41 per share. | 12 Feb 2025 | 22,526 | 25,049 (0%) | 0% | 14.4 | 324,600 | Common stock |
| Pegasystems Inc | Kerim Rifat Akgonul | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 22,500 | 30,000 | - | - | Stock Options | |
| Balchem Corp | Theodore L. Harris | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 22,364 | 90,601 (0%) | 0% | 0 | Common Stock | |
| Balchem Corp | Theodore L. Harris | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 22,364 | 90,601 (0%) | 0% | 0 | Common Stock | |
| 3M | Kevin H. Rhodes | EVP, Chief Legal Off & Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 22,174 | 22,174 | - | - | Non-qualified Stock Option (Right to Buy) | |
| NMI Holdings Inc (Class A) | William J. Leatherberry | Chief Admin. Officer & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Feb 2025 | 21,964 | 176,907 (0%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| Marcus Corp | Thomas F. Kissinger | Director, Sr Exec VP, Gen Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 21,960 | 208,545 (0%) | 0% | 0 | Common Stock | |
| Balchem Corp | Theodore L. Harris | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 21,500 | 21,500 | - | - | Stock Option | |
| Balchem Corp | Theodore L. Harris | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 21,500 | 21,500 | - | - | Stock Option | |
| Elme Communities | Tiffany Michelle Butcher | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 21,419 | 58,200 (0%) | 0% | 0 | Common Stock | |
| Cooper-Standard Holdings Inc | Christopher E. Couch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 21,080 | 21,080 | - | - | Restricted Stock Units | |
| Cooper-Standard Holdings Inc | Patrick R. Clark | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 21,080 | 21,080 | - | - | Restricted Stock Units | |
| Energy Services of America Corp | Mark S. Prince | Director | Purchase of securities on an exchange or from another person at price $ 10.96 per share. | 12 Feb 2025 | 21,000 | 100,071 | - | 11.0 | 230,160 | Common stock |
| NMI Holdings Inc (Class A) | Mohammad Yousaf | EVP, Chief of Ops and Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,904 | 58,527 (0%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| NMI Holdings Inc (Class A) | Norman P. Fitzgerald | EVP, Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,904 | 67,578 (0%) | 0% | 0 | Common Shares, $0.01 par value per share | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 20,861 | 787,240 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 20,861 | 41,722 | - | - | Restricted Stock Units | |
| Enovix Corp | Arthi Chakravarthy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,786 | 348,577 | - | 0 | Common Stock | |
| McDonald's | Desiree Ralls-Morrison | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,618 | 20,618 | - | - | Options (Right to Buy) | |
| McDonald's | Manuel JM Steijaert | EVP - Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,618 | 20,618 | - | - | Options (Right to Buy) | |
| Alight Inc (Class A) | Robert Sturrus W. | Chief Client Officer | 12 Feb 2025 | 20,583 | 77,975 | - | 0 | Class A Common Stock | ||
| Tractor Supply | John P. Ordus | EVP Chief Stores Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,561 | 20,561 | - | - | Employee stock option | |
| Cooper-Standard Holdings Inc | Patrick R. Clark | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 20,478 | 0 | - | - | Performance Stock Units | |
| Cooper-Standard Holdings Inc | Patrick R. Clark | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 20,478 | 20,478 (0%) | 0% | - | Common stock | |
| Cooper-Standard Holdings Inc | Patrick R. Clark | See Remarks | Sale or transfer of securities back to the company at price $ 14.41 per share. | 12 Feb 2025 | 20,478 | 0 (0%) | 0% | 14.4 | 295,088 | Common stock |
| 3M | Beatriz Karina Chavez Rodriguez | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,434 | 20,434 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Occidental Petroleum | Christopher O. Champion | VP, CAO and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,360 | 120,165 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Michael J. LaBarre | SVP, CHIEF TECHNICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,342 | 20,342 | - | - | Performance Stock Units | |
| CenterPoint Energy | Christopher A. Foster | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,295 | 159,828 (0%) | 0% | 0 | Common Stock | |
| Mondelez (Class A) | Mariano C. Lozano | EVP and President, LA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,282 | 20,282 (0%) | 0% | 0 | Class A Common Stock | |
| Alset Inc | Fai Heng Chan | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 12 Feb 2025 | 20,244 | 6,349,742 | - | 1.1 | 21,661 | Common Stock |
| Teradata Corp | Margaret A. Treese | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,111 | 116,894 (0%) | 0% | 0 | Common Stock | |
| Regency Centers - REIT | Michael J. Mas | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 20,035 | 81,959 (0%) | 0% | - | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 20,008 | 31,364 | - | - | Performance Stock Units | |
| Transdigm Group | Kevin M. Stein | President & CEO | 12 Feb 2025 | 20,000 | 28,158 (0%) | 0% | 195.9 | 3,917,600 | Common Stock | |
| Transdigm Group | Kevin M. Stein | President & CEO | 12 Feb 2025 | 20,000 | 113,500 | - | - | Stock Option | ||
| Cloudflare Inc (Class A) | Douglas Kramer | Chief Legal Officer | 12 Feb 2025 | 20,000 | 33,675 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Douglas Kramer | Chief Legal Officer | 12 Feb 2025 | 20,000 | 230,311 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Douglas Kramer | Chief Legal Officer | 12 Feb 2025 | 20,000 | 210,311 (0%) | 0% | 0 | Class A Common Stock | ||
| McDonald's | Morgan Edith Flatley | EVP - Global CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,869 | 19,869 | - | - | Options (Right to Buy) | |
| Rogers Corp | Randall Colin Gouveia | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,826 | 49,963 (0%) | 0% | 0 | Capital (Common) Stock | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.81 per share. | 12 Feb 2025 | 19,738 | 766,379 (0%) | 0% | 25.8 | 509,438 | Common Stock, par value $0.01 per share |
| Niagen Bioscience Inc | Carlos Luis Lopez | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,691 | 19,691 | - | - | Employee Stock Options (right to buy) | |
| NMI Holdings Inc (Class A) | William J. Leatherberry | Chief Admin. Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,677 | 155,619 | - | 0 | Restricted Stock Unit (right to receive) | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 12 Feb 2025 | 19,668 | 192,960,046 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 12 Feb 2025 | 19,668 | 19,668 (0%) | 0% | 0 | Class A Common Stock | ||
| Neurocrine Biosciences Inc | Kyle W. Gano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,628 | 19,628 | - | - | Restricted Stock Unit | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 19,562 | 798,593 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Element Soln Inc | Benjamin Gliklich H. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 19,562 | 19,561 | - | - | Restricted Stock Units | |
| Element Soln Inc | Richard L. Fricke | EVP, Head of Electronics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,373 | 19,373 | - | - | Performance Stock Units | |
| Joby Aviation Inc | Eric Allison | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 19,047 | 38,095 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Eric Allison | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 19,047 | 593,217 | - | 0 | Common Stock | |
| Joby Aviation Inc | Kate DeHoff | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 19,047 | 38,095 | - | - | Restricted Stock Units (RSUs) | |
| Joby Aviation Inc | Kate DeHoff | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 19,047 | 209,179 | - | 0 | Common Stock | |
| Vertex Pharma | Reshma Kewalramani | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 19,015 | 135,933 (0%) | 0% | 0 | Common Stock | |
| Vita Coco Co Inc | Jonathan Burth | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.10 per share. | 12 Feb 2025 | 18,900 | 104,108 | - | 40.1 | 757,814 | Common Stock |
| Vita Coco Co Inc | Jonathan Burth | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 18,900 | 49,525 | - | - | Non-Qualified Stock Option (right to buy) | |
| Vita Coco Co Inc | Jonathan Burth | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.18 per share. | 12 Feb 2025 | 18,900 | 123,008 | - | 10.2 | 192,364 | Common Stock |
| Vita Coco Co Inc | Ira Liran | Director | Sale of securities on an exchange or to another person at price $ 40.10 per share. | 12 Feb 2025 | 18,892 | 834,537 | - | 40.1 | 757,494 | Common Stock |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.45 per share. | 12 Feb 2025 | 18,759 | 716,987 | - | 45.5 | 852,655 | Class A Common Stock |
| Boyd Gaming Corp | Theodore A. Bogich | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 77.13 per share. | 12 Feb 2025 | 18,705 | 41,496 (0%) | 0% | 77.1 | 1,442,717 | Common Stock |
| CenterPoint Energy | Monica Karuturi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 18,646 | 153,390 (0%) | 0% | 0 | Common Stock | |
| Lightbridge Corp | Larry Goldman | CFO | Sale of securities on an exchange or to another person at price $ 14.09 per share. | 12 Feb 2025 | 18,303 | 150,900 (4%) | 0% | 14.1 | 257,889 | Common Stock |
| Laureate Education Inc | Marcelo Barbalho Cardoso | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 18,282 | 393,546 | - | 0 | Common Stock | |
| Teradata Corp | Kathleen R. Cullen-Cote | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 18,282 | 125,130 (0%) | 0% | 0 | Common Stock | |
| Teradata Corp | Michael D. Hutchinson | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 18,282 | 70,317 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.